HILLSBOROUGH, NJ, January 16, 2026 /24-7PressRelease/ -- Dr. Robert J. Britting Jr. has been included in Marquis Who's Who. As in all Marquis Who's Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process.

Dr. Britting has built a distinguished career in life sciences, demonstrating progressive leadership across commercial strategy, marketing, sales, and patient services. In 2024, he became U.S. Head of Customer Marketing for GSK Pharmaceuticals' vaccines division, leading cross-functional teams in retail, health care systems, patient access, and public sectors. He drove a customer-centric approach that aligned scientific value with real-world needs, focusing on modernizing commercialization and building trust through innovative engagement strategies and long-term partnerships.

In 2023, Dr. Britting founded RJB Consulting Partners LLC, where he serves as chief executive officer. Leveraging over 23 years of experience across general management, marketing leadership, executive sales, and innovation, the firm specializes in transforming business planning for pharmaceutical organizations. RJB Consulting Partners provides clients with practical, hands-on guidance and a sustainable operational model designed for long-term implementation. By adopting a "boots on the ground" philosophy, the firm forms true partnerships with its clients, focusing on aligning talent, enhancing organizational effectiveness, and driving strategic growth. The ultimate objective is to support both organizational goals and patient needs while driving demand for key business priorities.

Prior to GSK, Dr. Britting held multiple senior leadership roles at Teva Pharmaceuticals from 2020 to 2024. As senior director of U.S. marketing and North American innovation, he led patient services, digital health, and innovation initiatives while also serving as chief of staff to the U.S. executive team. Earlier roles included director of U.S. innovation and director of U.S. patient services and strategic solutions, where he focused on improving access, adherence, and delivering innovative, but practical patient experiences.

Earlier in his career, Dr. Britting served as U.S. enterprise consumer strategy and adherence marketing business lead at Novartis, guiding national adherence initiatives across multiple brands. From 2016 to 2018, he was the U.S. and marketing business lead for a blockbuster heart failure brand, where he played a vital role of the relaunch fostering its path to its blockbuster street expectations.

Dr. Britting previously held leadership positions at AstraZeneca Pharmaceuticals, including blockbuster and in-line products as a U.S. marketing lead for the respiratory franchise and U.S. and marketing lead for major cardiovascular products. His earlier progression included roles in sales leadership, training, and executive sales. He began his career with IQVIA as a pharmaceutical sales representative and earlier worked in national account management and healthcare communications.

Throughout his professional journey, Dr. Britting's peers and employees recognize him as a leader rooted in service, collaboration, and accountability. Organizations have sought his counsel for strategic insight, and he has served as a board advisor to Incedo Inc. and worked with Guidepoint prior to his role at GSK.

Dr. Britting earned a Doctor of Philosophy in applied management and decision science from Walden University, with concentrations in leadership and organizational change, a Master of Business Administration in marketing and management from La Salle University, and a Bachelor of Science in marketing and business administration from Gwynedd Mercy University. He attributes his success to strong family values, mentorship, and a commitment to lifelong learning.

In addition to his professional career, Dr. Britting has remained deeply engaged in public service. He served as mayor of Hillsborough Township, New Jersey, from 2024 to 2025 and as deputy mayor from 2023 to 2024, and he has been a member of the Hillsborough Township Committee since 2022. Dr. Britting has received multiple honors for leadership and public service from party leadership across both major political parties for Exemplary Excellence in Leadership as an Elected Official, sponsored by the New Jersey State Senate and General Assembly by Senator Bucco (R), Assemblywoman Dunn (R), Assemblyman Barranco (R), Senator Zwicker (D), Assemblyman Freiman (D) and Assemblywoman Drulis (D). Furthermore, Congress recognized Britting when he received a Congressional Honor for Transparency by Congressman Tom Kean Junior (R).

He values family life with his wife, Kelly, and is actively involved in mentoring and coaching his three children. Looking ahead, Dr. Britting remains focused on advancing trust-based engagement in the pharmaceutical industry while continuing to serve his community through principled, people-first leadership.

About Marquis Who's Who®:
Since 1899, when A. N. Marquis printed the First Edition of Who's Who in America®, Marquis Who's Who® has chronicled the lives of the most accomplished individuals and innovators from every significant field of endeavor, including politics, business, medicine, law, education, art, religion and entertainment. Who's Who in America® remains an essential biographical source for thousands of researchers, journalists, librarians and executive search firms around the world. The suite of Marquis® publications can be viewed at the official Marquis Who's Who® website, www.marquiswhoswho.com.

# # #